Akthelia Pharmaceuticals
PrivateLast Round
Grant
Oct 17, 2024
Total Funding Raised
$200,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Akthelia Pharmaceuticals is a biopharmaceutical company that develops small molecule therapeutics designed to enhance the body's innate immune defense mechanisms to treat mucosal and epithelial barrier-related diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Akthelia Pharmaceuticals Comparables
Compare Akthelia Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Promakhos Therapeutics | 78% | |
| Enzychem Lifesciences | 75% | |
| EpicentRx | 71% |
Akthelia Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 17, 2024 | ||||
| Grant | Apr 17, 2023 | ||||
| Pre Seed | Jan 1, 2022 | ||||
| Pre Seed | Dec 31, 2021 |
Key People
Founding team and executive leadership
Akthelia Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Rannís - The Icelandic Centre for Research | Grant |
| NSA Ventures | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 1133% MoM, from 43 to 530.
- Mar 1, 2026
Monthly visitors grew 150% MoM.
Akthelia Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Akthelia Pharmaceuticals's valuation, stock price, and market status.
Is Akthelia Pharmaceuticals a public or private company?
Akthelia Pharmaceuticals is a private company.
What is the current stock price of Akthelia Pharmaceuticals?
Akthelia Pharmaceuticals is a private company with no public stock price. Caplight tracks Akthelia Pharmaceuticals's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Akthelia Pharmaceuticals worth (valuation)?
Valuation information for Akthelia Pharmaceuticals is not publicly available.
Can I buy Akthelia Pharmaceuticals stock?
Akthelia Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Akthelia Pharmaceuticals's last funding round?
Akthelia Pharmaceuticals's most recent funding round was Grant on October 17, 2024.
Who are the main investors in Akthelia Pharmaceuticals?
Key investors in Akthelia Pharmaceuticals include Rannís - The Icelandic Centre for Research, NSA Ventures.
Will Akthelia Pharmaceuticals IPO soon?
No public IPO plans have been announced for Akthelia Pharmaceuticals.
How can I track Akthelia Pharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Akthelia Pharmaceuticals's secondary market activity and sign up for updates.